Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 898

Similar articles for PubMed (Select 15118656)

1.

A comparative review of the risks and benefits of hormone replacement therapy regimens.

Warren MP.

Am J Obstet Gynecol. 2004 Apr;190(4):1141-67. Review.

PMID:
15118656
2.

Postmenopausal hormone therapy: cardiovascular risks.

[No authors listed]

Prescrire Int. 2003 Apr;12(64):65-9.

PMID:
12674130
3.

Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.

[No authors listed]

Prescrire Int. 2004 Jun;13(71):106-9.

PMID:
15233153
4.
6.

Hormone therapy: evolving concepts.

Hendrix SL.

Curr Opin Rheumatol. 2003 Jul;15(4):464-8. Review.

PMID:
12819476
7.

New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; TREAT.

Maturitas. 2005 Sep 16;52(1):1-10. Review.

PMID:
15963666
8.

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE.

Am J Epidemiol. 2009 Jul 1;170(1):12-23. doi: 10.1093/aje/kwp115. Epub 2009 May 25.

9.

Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

Banks E, Canfell K.

Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25.

10.

Perspectives on the Women's Health Initiative trial of hormone replacement therapy.

Grimes DA, Lobo RA.

Obstet Gynecol. 2002 Dec;100(6):1344-53. Review.

PMID:
12468183
11.

Menopausal hormone therapy.

Bhavnani BR, Strickler RC.

J Obstet Gynaecol Can. 2005 Feb;27(2):137-62. Review.

PMID:
15937590
12.

Recent concerns surrounding HRT.

Armitage M, Nooney J, Evans S.

Clin Endocrinol (Oxf). 2003 Aug;59(2):145-55. Review.

PMID:
12864790
13.

Hormone replacement therapy update: who should we be prescribing this to now?

Kocjan T, Prelevic GM.

Curr Opin Obstet Gynecol. 2003 Dec;15(6):459-64. Review.

PMID:
14624210
15.

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.

Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J; Women's Health Initiative Investigators.

Am J Epidemiol. 2006 Apr 1;163(7):589-99. Epub 2006 Feb 16.

17.

Estrogen with and without progestin: benefits and risks of short-term use.

LaCroix AZ.

Am J Med. 2005 Dec 19;118 Suppl 12B:79-87.

PMID:
16414331
18.

[What scientific and clinical findings will result from the controlled trial "Women's Health Initiative"?].

Gaspard U.

Bull Mem Acad R Med Belg. 2003;158(1-2):133-41; discussion 141-5. French.

PMID:
12852099
19.

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators.

JAMA. 2002 Jul 17;288(3):321-33.

PMID:
12117397
20.

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J; Women's Health Initiative Investigators.

Am J Epidemiol. 2005 Sep 1;162(5):404-14. Epub 2005 Jul 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk